Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Xenon Pharmaceuticals Inc.”

102 pharma patents match "Xenon Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 4 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "Xenon Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “Xenon Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 8026360

    Substituted pyridazines as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted
  2. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  3. US 7951805

    Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

    Xenon Pharmaceuticals Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  4. US 7935721

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted
  5. US 7919484

    Combination therapy

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted
  6. US 7919496

    Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted
  7. US 7893206

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted
  8. US 7829712

    Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

    Xenon Pharmaceuticals Inc. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  9. US 7816075

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  10. US 7799798

    Spiroheterocyclic compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted
  11. US 7785886

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  12. US 7777036

    Heterocyclic derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted
  13. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  14. US 7763618

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  15. US 7759348

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  16. US 7754711

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  17. US 7700641

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  18. US 7696151

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  19. US 7659082

    Methods for identifying analgesic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  20. US 7605161

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted
  21. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted
  22. US 7547698

    Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

    Xenon Pharmaceuticals Inc. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  23. US 7514436

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted
  24. US 7511018

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted